Survival RateCell SurvivalSurvival AnalysisPrognosisTreatment OutcomeActuarial AnalysisDisease-Free SurvivalRetrospective StudiesFollow-Up StudiesForecastingTime FactorsSurvivalGraft SurvivalNeoplasmsKaplan-Meier EstimateNeoplasm StagingAntineoplastic AgentsAge FactorsRisk FactorsInfant, NewbornCombined Modality TherapyUnited StatesProportional Hazards ModelsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Recurrence, LocalLung NeoplasmsLiver NeoplasmsMultivariate AnalysisAdenocarcinomaQuestionnairesLymphatic MetastasisChemotherapy, AdjuvantProspective StudiesTumor Markers, BiologicalLiver TransplantationApoptosisCisplatinCarcinoma, HepatocellularCarcinoma, Squamous CellNeoplasm MetastasisBreast NeoplasmsImmunohistochemistryCohort StudiesPostoperative ComplicationsRecurrenceHepatectomyRegistriesRadiotherapy, AdjuvantStomach NeoplasmsDisease ProgressionCarcinoma, Non-Small-Cell LungDoxorubicinVincristineCyclophosphamideReoperationFluorouracilNeoplasm InvasivenessKidney TransplantationCell Line, TumorBrain NeoplasmsPancreatic NeoplasmsRadiotherapy DosageRisk AssessmentDrug Administration ScheduleLife TablesEsophageal NeoplasmsRemission InductionGraft RejectionCarcinomaColorectal NeoplasmsLymph Node ExcisionPredictive Value of TestsSignal TransductionTransplantation, HomologousMice, Inbred C57BLGastrectomyNeoadjuvant TherapyPrednisoneIncidenceDisease Models, AnimalEtoposideBile Duct NeoplasmsChemoembolization, TherapeuticTissue DonorsCell ProliferationBone NeoplasmsCardiopulmonary ResuscitationSEER ProgramRectal NeoplasmsHeart ArrestJapanSalvage TherapySarcomaGene Expression Regulation, NeoplasticRadiotherapyImmunosuppressive AgentsChi-Square DistributionCholangiocarcinomaDose FractionationCryopreservation